Intravitreal Bevacizumab to Treat Acute Central Serous Chorioretinopathy: Short-Term Effect
2009
Aims: To report the beneficial effect of intravitreal bevacizumab (Avastin) injection in patients with acute central serous chorioretinopathy. Methods: Ten eyes o
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
32
References
55
Citations
NaN
KQI